News Conference News EuroPCR 2015 Trials Explore the Potential of Biodegradable-Polymer Stents Caitlin E. Cox May 21, 2015
News Conference News EuroPCR 2015 DEFLECT III: 30-Day Results Show Successful, Safe TAVR With Novel Neuroprotection Device Yael L. Maxwell May 20, 2015
News Conference News EuroPCR 2015 Evolving DES Technology May Benefit Diabetic Patients Caitlin E. Cox May 19, 2015
News Conference News EuroPCR 2014 UK Registry Finds Long-Term Survival After TAVR Depends on Patient Characteristics Caitlin E. Cox May 22, 2014
News Conference News EuroPCR 2014 EuroPCR Features PAD Therapies in Early Development and Real-World Use Caitlin E. Cox May 21, 2014
News Conference News EuroPCR 2013 EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges Caitlin E. Cox May 29, 2013
News Conference News EuroPCR 2013 ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients Caitlin E. Cox May 24, 2013
News Conference News EuroPCR 2013 RIPCORD Study: FFR Results Change Path of Patient Management Caitlin E. Cox May 23, 2013
News Conference News EuroPCR 2013 Novel ‘3D’ Stent Improves Clinical Status in Femoropopliteal Disease Patients Jason Kahn May 23, 2013
News Conference News EuroPCR 2013 Novel Stent Helps Treat Bifurcation Lesions in FIM Registry Jason Kahn May 22, 2013
News Conference News EuroPCR 2012 TAVR Studies Tease Out Influences on Clinical Outcome Caitlin E. Cox May 18, 2012
News Conference News EuroPCR 2012 OCT-Guided PCI Improves 1-Year Outcomes vs. Angiography Alone Jason Kahn May 18, 2012
News Conference News EuroPCR 2012 Trials Take on Permanent- vs. Biodegradable-Polymer Technology Caitlin E. Cox May 17, 2012
News Conference News EuroPCR 2012 Mixed Results Shown with Adenosine-Free Pressure Measurement vs. FFR Jason Kahn May 16, 2012
News Conference News POST-AMI: Postconditioning Not Helpful, Possibly Harmful in STEMI Patients Caitlin E. Cox May 19, 2011
News Conference News DISCOVER-FLOW: CT-Derived FFR Measurements Show High Diagnostic Accuracy Caitlin E. Cox May 18, 2011
News Conference News RECLOSE 2-ACS: Poor Responders Show Poor Outcomes Despite Higher Clopidogrel Dose Caitlin E. Cox May 18, 2011